New anti-angiogenic compound based on chemically modified heparin. Kniggendorf V, Souza MEP, Russo T, de Lima MA, et al. Graefes Arch Clin Exp Ophthalmol 2022;260:3847-3855.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kniggendorf V, Souza MEP, Russo T, de Lima MA, et al. New anti-angiogenic compound based on chemically modified heparin. Graefes Arch Clin Exp Ophthalmol 2022;260:3847-3855.
PMID: 36097187